Editorial
doi: 10.1016/j.ijcha.2019.100417.
eCollection 2019 Sep.
No-reflow phenomenon in acute myocardial infarction: Relieve pressure from the procedure and focus attention to the patient
Affiliations
- PMID: 31508482
- PMCID: PMC6723373
- DOI: 10.1016/j.ijcha.2019.100417
Item in Clipboard
Editorial
No-reflow phenomenon in acute myocardial infarction: Relieve pressure from the procedure and focus attention to the patient
Int J Cardiol Heart Vasc.
.
No abstract available
Comment on
- doi: 10.1016/j.ijcha.2019.100412
Similar articles
-
Long-term compound danshen dripping pills therapy reduces the no-reflow phenomenon in nondiabetes mellitus patients after primary percutaneous coronary intervention for acute myocardial infarction.Ann Palliat Med. 2020 May;9(3):1144-1151. doi: 10.21037/apm-20-1056. Ann Palliat Med. 2020. PMID: 32498529
-
The Elevated Soluble ST2 Predicts No-Reflow Phenomenon in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.J Atheroscler Thromb. 2019 Nov 1;26(11):970-978. doi: 10.5551/jat.48413. Epub 2019 Apr 18. J Atheroscler Thromb. 2019. PMID: 30996145 Free PMC article. Clinical Trial.
-
No-reflow phenomenon and in vivo cholesterol crystals combined with lipid core in acute myocardial infarction.Int J Cardiol Heart Vasc. 2022 Jan 11;38:100953. doi: 10.1016/j.ijcha.2022.100953. eCollection 2022 Feb. Int J Cardiol Heart Vasc. 2022. PMID: 35059493 Free PMC article.
-
Coronary microvascular reperfusion injury and no-reflow in acute myocardial infarction.Clin Invest Med. 2007;30(3):E133-45. doi: 10.25011/cim.v30i3.1082. Clin Invest Med. 2007. PMID: 17716552 Review.
-
The "no reflow" phenomenon following acute myocardial infarction: mechanisms and treatment options.J Cardiol. 2014 Aug;64(2):77-85. doi: 10.1016/j.jjcc.2014.03.008. Epub 2014 May 3. J Cardiol. 2014. PMID: 24799155 Review.
Cited by
-
Single Center Trends in Acute Coronary Syndrome Volume and Outcomes During the COVID-19 Pandemic.Cardiol Res. 2020 Aug;11(4):256-259. doi: 10.14740/cr1096. Epub 2020 Jun 3. Cardiol Res. 2020. PMID: 32595811 Free PMC article.
-
Prevalence and prognostic implications of the no-reflux phenomenon in patients undergoing primary percutaneous coronary intervention at a university center in a middle-income country.Arch Cardiol Mex. 2024;94(3):331-340. doi: 10.24875/ACM.23000120. Arch Cardiol Mex. 2024. PMID: 39028873 Free PMC article. English.
-
Predictive value of the triglyceride-glucose index for no-reflow phenomenon after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction complicated by metabolic syndrome.Am J Transl Res. 2024 Oct 15;16(10):5539-5551. doi: 10.62347/HQVS4428. eCollection 2024. Am J Transl Res. 2024. PMID: 39544805 Free PMC article.
References
-
- Harrison R.W., Aggarwal A., Ou F.S., Klein L.W., Rumsfeld J.S., Roe M.T. Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction. Am. J. Cardiol. 2013;111(2):178–184. - PubMed
-
- Choo E.H., Kim P.J., Chang K., Ahn Y., Jeon D.S., Lee J.M., Kim D.B., Her S.H., Park C.S., Kim H.Y., Yoo K.D., Jeong M.H., Seung K.B. The impact of no-reflow phenomena after primary percutaneous coronary intervention: a time-dependent analysis of mortality. Coron. Artery Dis. 2014;25(5):392–398. Aug. - PubMed
-
- Ndrepepa G., Tiroch K., Fusaro M., Keta D., Seyfarth M., Byrne R.A. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J. Am. Coll. Cardiol. 2010;55(21):2383–2389. - PubMed
-
- Rezkalla S.H., Stankowski R.V., Hanna J., Kloner R.A. Management of no-Reflow Phenomenon in the catheterization laboratory. JACC Cardiovasc Interv. 2017;10(3):215–223. Feb 13. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
